- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Elbit purchase of Diasonics approved
At their annual meeting lastweek, Diasonics Ultrasound stockholders approved the acquisitionof their company by Israeli technology firm Elbit. Haifa-basedElbit, the parent of medical imaging vendor Elscint, announcedthat it would buy Diasonics in July
At their annual meeting lastweek, Diasonics Ultrasound stockholders approved the acquisitionof their company by Israeli technology firm Elbit. Haifa-basedElbit, the parent of medical imaging vendor Elscint, announcedthat it would buy Diasonics in July (SCAN 7/27/94). Diasonicsis based in Milpitas, CA.
The acquisition has also received approval from the FederalTrade Commission, and became effective as of the close of businesson Oct. 19. Diasonics shareholders received $5.512 in cash foreach share of Diasonics stock.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
